Bone marrow stem cell therapy for renal regeneration after acute tubular necrosis

A dream or a reality?

Te Chao Fang, Chih Hsien Wang, Jen Pi Tsai, Bang Gee Hsu

Research output: Contribution to journalArticle

Abstract

Bone marrow transplantation and organ transplantation studies suggest that bone marrow cells can differentiate into a variety of non-hematological tissues, including renal cells. The results of a number of experimental animal studies also showed that cell therapy (bone marrow cells (BMCs), hematopoietic stem cells (HSCs), mesenchymal stem cells (MSCs)) might have the potential to rescue animals from organ injuries. However, when BMCs or HSCs were injected into rodents subjected to ischemic or toxin-induced acute tubular necrosis (ATN), the results with regard to whether they could rescue rodents from ATN were inconsistent. The reasons for the conflicting results of BMC or HSC therapy in ATN are unknown, but may be due to the different types of cells injected, number of cells injected, route of injection, or injury model of acute renal failure. It is known that MSCs can contribute to renal tubular regeneration after ATN, although the exact mechanism, either transdifferentiation or effects of paracrine/cytokines, is uncertain. In the future, the most pertinent issue is to determine how MSCs protect the renal tubule from injury, and then to imitate this protective or reparative effect pharmacologically.

Original languageEnglish
Pages (from-to)115-126
Number of pages12
JournalTzu Chi Medical Journal
Volume19
Issue number3
Publication statusPublished - Sep 2007
Externally publishedYes

Fingerprint

Cell- and Tissue-Based Therapy
Bone Marrow Cells
Regeneration
Necrosis
Stem Cells
Hematopoietic Stem Cells
Mesenchymal Stromal Cells
Kidney
Rodentia
Wounds and Injuries
Animal Structures
Organ Transplantation
Bone Marrow Transplantation
Acute Kidney Injury
Cell Count
Cytokines
Injections

Keywords

  • Acute tubular necrosis
  • Bone marrow cells
  • Hematopoietic stem cells
  • Mesenchymal stem cells

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Bone marrow stem cell therapy for renal regeneration after acute tubular necrosis : A dream or a reality? / Fang, Te Chao; Wang, Chih Hsien; Tsai, Jen Pi; Hsu, Bang Gee.

In: Tzu Chi Medical Journal, Vol. 19, No. 3, 09.2007, p. 115-126.

Research output: Contribution to journalArticle

Fang, Te Chao ; Wang, Chih Hsien ; Tsai, Jen Pi ; Hsu, Bang Gee. / Bone marrow stem cell therapy for renal regeneration after acute tubular necrosis : A dream or a reality?. In: Tzu Chi Medical Journal. 2007 ; Vol. 19, No. 3. pp. 115-126.
@article{131f8c10907b45f492ace1abdfc6ef55,
title = "Bone marrow stem cell therapy for renal regeneration after acute tubular necrosis: A dream or a reality?",
abstract = "Bone marrow transplantation and organ transplantation studies suggest that bone marrow cells can differentiate into a variety of non-hematological tissues, including renal cells. The results of a number of experimental animal studies also showed that cell therapy (bone marrow cells (BMCs), hematopoietic stem cells (HSCs), mesenchymal stem cells (MSCs)) might have the potential to rescue animals from organ injuries. However, when BMCs or HSCs were injected into rodents subjected to ischemic or toxin-induced acute tubular necrosis (ATN), the results with regard to whether they could rescue rodents from ATN were inconsistent. The reasons for the conflicting results of BMC or HSC therapy in ATN are unknown, but may be due to the different types of cells injected, number of cells injected, route of injection, or injury model of acute renal failure. It is known that MSCs can contribute to renal tubular regeneration after ATN, although the exact mechanism, either transdifferentiation or effects of paracrine/cytokines, is uncertain. In the future, the most pertinent issue is to determine how MSCs protect the renal tubule from injury, and then to imitate this protective or reparative effect pharmacologically.",
keywords = "Acute tubular necrosis, Bone marrow cells, Hematopoietic stem cells, Mesenchymal stem cells",
author = "Fang, {Te Chao} and Wang, {Chih Hsien} and Tsai, {Jen Pi} and Hsu, {Bang Gee}",
year = "2007",
month = "9",
language = "English",
volume = "19",
pages = "115--126",
journal = "Tzu Chi Medical Journal",
issn = "1016-3190",
publisher = "財團法人中華民國佛教慈濟慈善事業基金會",
number = "3",

}

TY - JOUR

T1 - Bone marrow stem cell therapy for renal regeneration after acute tubular necrosis

T2 - A dream or a reality?

AU - Fang, Te Chao

AU - Wang, Chih Hsien

AU - Tsai, Jen Pi

AU - Hsu, Bang Gee

PY - 2007/9

Y1 - 2007/9

N2 - Bone marrow transplantation and organ transplantation studies suggest that bone marrow cells can differentiate into a variety of non-hematological tissues, including renal cells. The results of a number of experimental animal studies also showed that cell therapy (bone marrow cells (BMCs), hematopoietic stem cells (HSCs), mesenchymal stem cells (MSCs)) might have the potential to rescue animals from organ injuries. However, when BMCs or HSCs were injected into rodents subjected to ischemic or toxin-induced acute tubular necrosis (ATN), the results with regard to whether they could rescue rodents from ATN were inconsistent. The reasons for the conflicting results of BMC or HSC therapy in ATN are unknown, but may be due to the different types of cells injected, number of cells injected, route of injection, or injury model of acute renal failure. It is known that MSCs can contribute to renal tubular regeneration after ATN, although the exact mechanism, either transdifferentiation or effects of paracrine/cytokines, is uncertain. In the future, the most pertinent issue is to determine how MSCs protect the renal tubule from injury, and then to imitate this protective or reparative effect pharmacologically.

AB - Bone marrow transplantation and organ transplantation studies suggest that bone marrow cells can differentiate into a variety of non-hematological tissues, including renal cells. The results of a number of experimental animal studies also showed that cell therapy (bone marrow cells (BMCs), hematopoietic stem cells (HSCs), mesenchymal stem cells (MSCs)) might have the potential to rescue animals from organ injuries. However, when BMCs or HSCs were injected into rodents subjected to ischemic or toxin-induced acute tubular necrosis (ATN), the results with regard to whether they could rescue rodents from ATN were inconsistent. The reasons for the conflicting results of BMC or HSC therapy in ATN are unknown, but may be due to the different types of cells injected, number of cells injected, route of injection, or injury model of acute renal failure. It is known that MSCs can contribute to renal tubular regeneration after ATN, although the exact mechanism, either transdifferentiation or effects of paracrine/cytokines, is uncertain. In the future, the most pertinent issue is to determine how MSCs protect the renal tubule from injury, and then to imitate this protective or reparative effect pharmacologically.

KW - Acute tubular necrosis

KW - Bone marrow cells

KW - Hematopoietic stem cells

KW - Mesenchymal stem cells

UR - http://www.scopus.com/inward/record.url?scp=35348987751&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=35348987751&partnerID=8YFLogxK

M3 - Article

VL - 19

SP - 115

EP - 126

JO - Tzu Chi Medical Journal

JF - Tzu Chi Medical Journal

SN - 1016-3190

IS - 3

ER -